Neurinnov
Developer of an implantable neurostimulation platform that uses multi-contact nerve electrodes and embedded electronics to selectively steer electrical currents within peripheral nerves. The company has published early clinical feasibility results showing restored hand grasp in patients with complete tetraplegia and is advancing the platform toward industrial development, regulatory certification, and pivotal clinical trials.
Industries
Nr. of Employees
small (1-50)
Neurinnov
Products
Implantable neurostimulator platform for selective peripheral nerve stimulation
An implantable system composed of an embedded stimulation ASIC, implant casing, multi-contact nerve electrodes, and an external controller enabling wireless power/data transfer and patient control through multiple interfaces.
Implantable neurostimulator platform for selective peripheral nerve stimulation
An implantable system composed of an embedded stimulation ASIC, implant casing, multi-contact nerve electrodes, and an external controller enabling wireless power/data transfer and patient control through multiple interfaces.
Services
Participation in multi-partner European projects and collaborations with academic, medical and industrial partners to develop and validate selective neural stimulation therapies.
Participation in multi-partner European projects and collaborations with academic, medical and industrial partners to develop and validate selective neural stimulation therapies.
Expertise Areas
- Selective neural stimulation
- Implantable medical device design (AIMD architecture)
- Early-phase clinical feasibility and trial execution
- Neuroengineering and electrophysiology
Key Technologies
- Application-specific integrated circuits (ASICs) for stimulation control
- Multi-contact epineural cuff electrodes
- 3D current steering / current shaping
- Transcutaneous energy transfer (wireless power/data)
News & Updates
Awarded a €2.5M grant from the European Innovation Council Accelerator to support clinical, regulatory and industrial development and upcoming pivotal clinical trial.
Participation in a HORIZON project to design and develop a multi-contact neural stimulator combining biomaterials, pharmaceuticals and electrical stimulation in preclinical models.
Partner in an EU-funded project to restore hand function using selective neural electrical stimulation.
Clinical study results demonstrating restoration of hand control in patients with high spinal cord injuries, published in peer-reviewed journals.
Received regional award recognizing the implantable neurostimulator concept and prototype.
Awarded a €2.5M grant from the European Innovation Council Accelerator to support clinical, regulatory and industrial development and upcoming pivotal clinical trial.
Participation in a HORIZON project to design and develop a multi-contact neural stimulator combining biomaterials, pharmaceuticals and electrical stimulation in preclinical models.
Partner in an EU-funded project to restore hand function using selective neural electrical stimulation.
Clinical study results demonstrating restoration of hand control in patients with high spinal cord injuries, published in peer-reviewed journals.
Received regional award recognizing the implantable neurostimulator concept and prototype.